47. バージャー病 Buerger disease Clinical trials / Disease details

臨床試験数 : 9 / 薬物数 : 13 - (DrugBank : 7) / 標的遺伝子数 : 6 - 標的パスウェイ数 : 15

diseases per page:

Showing 1 to 9 of 9 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	ChiCTR2100048104	2021-08-01	2021-07-01	A clinical study of safety and efficacy of transcatheter intra-arterial infusion of extract of Ginkg ...	A clinical study of safety and efficacy of transcatheter intra-arterial infusion of extract of Ginkg ...	Thromboangiitis Obliterans	Treatment group:Transcatheter intra-arterial infusion of Ginkgo bilobaleaves injection;Control group: ...	First Clinical Center of Chinese PLA General Hospital	NULL	Pending		50	Both	Treatment group:30;Control group:30;		China
2	NCT04914247 (ClinicalTrials.gov)	June 15, 2021	31/5/2021	Individual Patient Expanded Access IND for Selexipag (Uptravi) in Participants With Non-healing Woun ...	Individual Patient Expanded Access IND for Selexipag (Uptravi) in Participants With Non-healing Woun ...	Non-healing Wound;Thromboangiitis Obliterans	Drug: Selexipag	Actelion	NULL	Available						NULL
3	NCT02501018 (ClinicalTrials.gov)	November 1, 2017	14/7/2015	Study to Assess the Efficacy and Safety of CLBS12 in Patients With Critical Limb Ischemia (CLI)	A Prospective, Open Label, Controlled, Randomized, Multicenter Study to Assess the Efficacy and Safe ...	Critical Limb Ischemia;Buerger Disease;Thromboangiitis Obliterans;Atherosclerosis Obliterans	Biological: CLBS12;Drug: SOC	Caladrius Biosciences, Inc.	NULL	Recruiting	20 Years	85 Years	All	35	Phase 2	Japan
4	NCT03056742 (ClinicalTrials.gov)	February 20, 2017	23/1/2017	A Clinical Trial to Study the Efficacy and Safety of Stempeucel® in Patients With CLI Due to Buerger ...	A Single Arm, Open Label, Multicentric, Clinical Study Assessing the Efficacy and Safety of Stempeuc ...	Critical Limb Ischemia Due to Buerger's Disease	Biological: Stempeucel(R)	Stempeutics Research Pvt Ltd	NULL	Withdrawn	18 Years	65 Years	All	0	Phase 2	India
5	JPRN-UMIN000021374	2016/03/07	07/03/2016	Ex Vivo Expanded Erythroblast-Transplantation for patient with critical limb ischemia	Ex Vivo Expanded Erythroblast-Transplantation for patient with critical limb ischemia - EVEETA study ...	Peripheral Arterial Disease (PAD) , Buerger disease, and arteritis associated with collagen diseases ...	1)Autologous Bone Marrow Collection: 40 to 60 ml of bone marrow is collected from iliaccrest under l ...	EVEETA Study Group	NULL	Complete: follow-up complete	20years-old	80years-old	Male and Female	11	Not selected	Japan
6	NCT01484574 (ClinicalTrials.gov)	January 2012	27/11/2011	A Clinical Trial to Study the Efficacy and Safety of Different Doses of Bone Marrow Derived Mesenchy ...	A Non-randomized, Open Label, Multicentric, Dose Ranging , Phase II Study Assessing the Efficacy and ...	Critical Limb Ischemia;Buerger's Disease	Biological: Allogeneic Mesenchymal Stem Cells	Stempeutics Research Pvt Ltd	NULL	Completed	18 Years	65 Years	Both	90	Phase 2	India
7	JPRN-UMIN000005227	2011/03/01	09/03/2011	Transplantation of autologous and G-CSF mobilized mononuclear cells in patients with critical limb i ...		CLI (Atherosclerotic PAD/Buerger disease )	Subcutaneous administration of G-CSF, Harvest and implantation of PB-MNC	Regenerative Medicine Unit, Division of Vascular Regeneration Therapy, Institute of Biomedical Resea ...	NULL	Complete: follow-up complete	20years-old	80years-old	Male and Female	5	Not selected	Japan
8	NCT01447550 (ClinicalTrials.gov)	January 2009	5/10/2011	Treatment of Thromboangiitis Obliterans (Buerguer's Disease) With Bosentan	Treatment of Thromboangiitis Obliterans (Buerger's Disease) With Bosentan	Thromboangiitis Obliterans	Drug: Bosentan	Hospital Universitario Getafe	NULL	Completed	18 Years	65 Years	Both	12	N/A	Spain
9	NCT01302015 (ClinicalTrials.gov)	December 2007	17/2/2011	Autologous Adipose Tissue Derived Mesenchymal Stem Cells Transplantation in Patient With Buerger's D ...	Safety and Efficacy of Autologous Adipose Tissue Derived Mesenchymal Stem Cells Transplantation in P ...	Buerger's Disease	Biological: RNL-Vascostem®	R-Bio	NULL	Completed	20 Years	80 Years	All	15	N/A	Korea, Republic of

First Previous1Next Last